Boltz Launches BoltzMol-1, BoltzProt-1, and a New API for Small Molecule Hit Discovery and De Novo Binder Design (opens in new tab)

Drug discovery has always been brutally slow. You pick a target, screen hundreds of thousands of compounds, watch most of them fail, spend months on each experiment, and pray that something sticks. For most research teams, especially in academia, that process is simply out of reach. The cost alone can run into the tens of […] The post appeared first on <a href="